|
|
Trimovax Merieux powder and solvent for susp. for inj.
| |
| Rinkodaros teisės |
Pasteur Merieux Serums & Vaccins S.A., Prancūzija
|
| Registracijos nr. |
95/1915/2
|
| Būsena i |
neregistruotas
|
| |
| Pavadinimas |
Trimovax Merieux
|
| Forma |
powder and solvent for susp. for inj.
|
| Vartojimas |
nenurodytas
|
| Veiklioji medžiaga |
Attenuated live measles virus (Schwarz strain)+Attenuated live mumps virus (Urabe AM 9 strain)+Attenuated live rubella virus (Wistar RA 27/3 strain) |
| Stiprumas |
>1000CCID50+>5000CCID50+>1000CCID50/dose
|
| Išdavimo tvarka i |
receptinis
|
| |
| ATC kodas |
J07BD52
|
| |
Morbilli, combinations with parotitis and rubella, live attenuated
|
| Pakuotė |
Reg. Nr. |
|
Kompensavimas i |
| MK |
BK |
Paciento priemoka |
| 100% |
90% |
80% |
50% |
|
Trimovax Merieux powder and solvent for susp. for inj. 0,5 ml single dose vial+syringe 0,5 ml of diluent N1 |
95/1915/2
|
|
|
|
|
|
|
|
|
2024 balandžio 18 d., ketvirtadienis 
